Personalized Medicine

March 6, 2013 (All day)

 

The Fox Center for Vision Restoration organizes an exciting lecture series focusing on ocular regeneration and new therapies.

Distinguished national and international speakers present their innovative and multidisciplinary approaches to finding cures for vision impairment. The objective of this lecture series is to accelerate research through knowledge sharing, partnership building and out of the box thinking.

Personalized MedicineStephen H. Tsang

Stephen H. Tsang, MD, PhD
Associate Professor in Ophthalmology
College of Physicians & Surgeons
Associate Professor in Pathology & Cell Biology
Graduate School of Arts & Sciences
Columbia University Medical Center

Dr. Stephen Tsang is an Associate Professor in Ophthalmology at Columbia University Medical Center. He earned both his MD (1998) and his PhD (1996)at Columbia University.

Dr. Tsang focuses his research on finding new treatments for photoreceptor degeneration in retinitis pigmentosa (RP), age-related macular degeneration (AMD) and related retinal dystrophies, which are the most common forms of degenerative disease in the central nervous system and have profound impact on quality of life.

Presentation abstract

When the human genome was finally sequenced in 2003, the project had taken 15 years and cost approximately three billion dollars. Today, any individual can have his genome sequenced within two months at a cost of $5,000. The rapid explosion of new knowledge about genetics (and associated fields like proteomics) has ushered in a new age of personalized medicine. Instead of treating everyone with a certain disease with the exact same therapy, physicians can analyze individual genetic and molecular variations to help determine how a patient will respond to a particular medication. Patients will react to a therapeutic agent based on their genetic makeup, so one would screen patients, who are receiving a drug, for their genetic profile. The current stem cell technology allow us to derive and repair patient-specific cell lines to treat individuals with various diseases, and the second is to screen therapeutic agents to ascertain if they will be effective for specific patients or not.
 

Location and Address

Eye and Ear Boardroom, 5th floor, Eye and Ear Institute 203 Lothrop Street, Pittsburgh PA 15213